Abliva AB Performance
| NEVPFDelisted Stock | USD 0.03 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.53, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Abliva AB's returns are expected to increase less than the market. However, during the bear market, the loss of holding Abliva AB is expected to be smaller as well. Abliva AB right now shows a risk of 0.0%. Please confirm Abliva AB variance, skewness, as well as the relationship between the Skewness and day typical price , to decide if Abliva AB will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Abliva AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Abliva AB is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 61.6 M | |
| Total Cashflows From Investing Activities | -1.1 M |
Abliva |
Abliva AB Relative Risk vs. Return Landscape
If you would invest 2.80 in Abliva AB on September 28, 2025 and sell it today you would earn a total of 0.00 from holding Abliva AB or generate 0.0% return on investment over 90 days. Abliva AB is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Abliva, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Abliva AB Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Abliva AB's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Abliva AB, and traders can use it to determine the average amount a Abliva AB's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| NEVPF |
Based on monthly moving average Abliva AB is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abliva AB by adding Abliva AB to a well-diversified portfolio.
Abliva AB Fundamentals Growth
Abliva Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Abliva AB, and Abliva AB fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Abliva Pink Sheet performance.
| Return On Equity | -0.8 | |||
| Return On Asset | -0.41 | |||
| Current Valuation | 10.01 M | |||
| Shares Outstanding | 1.06 B | |||
| Price To Earning | (2.49) X | |||
| Price To Book | 0.60 X | |||
| Price To Sales | 765.58 X | |||
| Revenue | 151 K | |||
| EBITDA | (120.72 M) | |||
| Cash And Equivalents | 4.32 M | |||
| Cash Per Share | 0.06 X | |||
| Book Value Per Share | 0.17 X | |||
| Cash Flow From Operations | (114.08 M) | |||
| Earnings Per Share | (0.11) X | |||
| Total Asset | 58.92 M | |||
| Retained Earnings | (29.41 M) | |||
| Current Asset | 13.44 M | |||
| Current Liabilities | 1.24 M | |||
About Abliva AB Performance
By analyzing Abliva AB's fundamental ratios, stakeholders can gain valuable insights into Abliva AB's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Abliva AB has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Abliva AB has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Abliva AB develops medicines for the treatment of primary mitochondrial diseases. Abliva AB was incorporated in 2000 and is headquartered in Lund, Sweden. ABLIVA AB is traded on OTC Exchange in the United States.Things to note about Abliva AB performance evaluation
Checking the ongoing alerts about Abliva AB for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Abliva AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Abliva AB is not yet fully synchronised with the market data | |
| Abliva AB has some characteristics of a very speculative penny stock | |
| Abliva AB has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 151 K. Net Loss for the year was (123.49 M) with loss before overhead, payroll, taxes, and interest of (103.54 M). | |
| Abliva AB has accumulated about 4.32 M in cash with (114.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Abliva AB's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Abliva AB's stock is overvalued or undervalued compared to its peers.
- Examining Abliva AB's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Abliva AB's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Abliva AB's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Abliva AB's pink sheet. These opinions can provide insight into Abliva AB's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Abliva Pink Sheet
If you are still planning to invest in Abliva AB check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Abliva AB's history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |